II
GILD icon

IFM Investors’s Gilead Sciences GILD Stock Holding History

IFM Investors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.4M Buy
287,894
+25,609
+10% +$3.37M 0.24% 73
2026
Q1 		$36.6M Buy
262,285
+6,421
+3% +$899K 0.3% 62
2025
Q4 		$31.4M Buy
255,864
+298
+0.1% +$36.2K 0.26% 73
2025
Q3 		$28.6M Sell
255,566
-1,098
-0.4% -$125K 0.25% 78
2025
Q2 		$28.5M Buy
256,664
+2,635
+1% +$280K 0.27% 69
2025
Q1 		$28.5M Buy
254,029
+5,079
+2% +$524K 0.31% 64
2024
Q4 		$23M Sell
248,950
-21,655
-8% -$1.95M 0.23% 80
2024
Q3 		$22.7M Buy
270,605
+293
+0.1% +$22.4K 0.22% 87
2024
Q2 		$18.5M Buy
270,312
+1,592
+0.6% +$106K 0.19% 99
2024
Q1 		$19.7M Sell
268,720
-1,760
-0.7% -$135K 0.21% 93
2023
Q4 		$21.9M Sell
270,480
-3,044
-1% -$237K 0.27% 75
2023
Q3 		$20.5M Buy
273,524
+9,878
+4% +$760K 0.27% 73
2023
Q2 		$20.3M Buy
263,646
+13,474
+5% +$1.07M 0.27% 77
2023
Q1 		$20.8M Buy
250,172
+6,907
+3% +$572K 0.31% 64
2022
Q4 		$20.9M Buy
243,265
+20,685
+9% +$1.64M 0.35% 60
2022
Q3 		$13.7M Sell
222,580
-324
-0.1% -$20.4K 0.25% 81
2022
Q2 		$13.8M Buy
222,904
+17,215
+8% +$1.07M 0.24% 84
2022
Q1 		$12.2M Buy
205,689
+34,008
+20% +$2.17M 0.19% 101
2021
Q4 		$12.5M Sell
171,681
-791
-0.5% -$54.5K 0.23% 87
2021
Q3 		$12M Sell
172,472
-97
-0.1% -$6.82K 0.25% 81
2021
Q2 		$11.9M Buy
172,569
+33,459
+24% +$2.23M 0.24% 83
2021
Q1 		$8.99M Buy
139,110
+17,920
+15% +$1.16M 0.24% 87
2020
Q4 		$7.06M Buy
121,190
+17,762
+17% +$1.07M 0.22% 93
2020
Q3 		$6.54M Buy
103,428
+10,582
+11% +$734K 0.27% 71
2020
Q2 		$7.14M Sell
92,846
-33,220
-26% -$2.55M 0.37% 57
2020
Q1 		$9.57M Sell
126,066
-4,744
-4% -$328K 0.43% 52
2019
Q4 		$8.5M Sell
130,810
-6,491
-5% -$423K 0.3% 69
2019
Q3 		$8.7M Buy
137,301
+46,723
+52% +$3.05M 0.32% 67
2019
Q2 		$6.12M Buy
90,578
+6,169
+7% +$406K 0.35% 61
2019
Q1 		$5.49M Buy
84,409
+9,370
+12% +$623K 0.35% 60
2018
Q4 		$4.69M Buy
75,039
+6,573
+10% +$459K 0.38% 58
2018
Q3 		$5.29M Buy
68,466
+9,342
+16% +$706K 0.4% 54
2018
Q2 		$4.19M Buy
59,124
+18,536
+46% +$1.31M 0.4% 54
2018
Q1 		$3.06M Buy
40,588
+4,074
+11% +$324K 0.44% 49
2017
Q4 		$2.62M Sell
36,514
-108
-0.3% -$8.2K 0.41% 49
2017
Q3 		$2.97M Buy
36,622
+743
+2% +$56.8K 0.5% 41
2017
Q2 		$2.54M Buy
35,879
+8,972
+33% +$597K 0.46% 44
2017
Q1 		$1.83M Buy
26,907
+9,974
+59% +$701K 0.46% 43
2016
Q4 		$1.21M Buy
+16,933
New +$1.26M 0.57% 40

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

IFM Investors's GILD Position: Q2 2026 in Review

IFM Investors increased its Gilead Sciences (GILD) stake by 9.8% in Q2 2026, buying an estimated $3.37M and bringing the position to 287,894 shares worth $36.4M. The position accounts for 0.24% of the portfolio, ranked #73.

IFM Investors first reported a position in GILD in Q4 2016 and has held it in 39 quarters since. The position peaked at $36.6M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • IFM Investors held 287,894 shares of Gilead Sciences worth $36.4M as of Q2 2026.
  • IFM Investors bought 25,609 Gilead Sciences shares in Q2 2026, an estimated $3.37M.
  • Gilead Sciences made up 0.24% of IFM Investors's portfolio in Q2 2026, its #73 holding.
  • IFM Investors first reported a position in Gilead Sciences in Q4 2016 and has held it in 39 quarters since.
  • IFM Investors's Gilead Sciences position peaked at $36.6M in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.